Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by FOXM1 is a transcriptional activator involved in cell proliferation. Additionally we are shipping FOXM1 Proteins (7) and FOXM1 Kits (1) and many more products for this protein.
Showing 10 out of 93 products:
Dog (Canine) Polyclonal FOXM1 Primary Antibody for WB - ABIN2781166
Laoukili, Alvarez, Meijer, Stahl, Mohammed, Kleij, Heck, Medema: Activation of FoxM1 during G2 requires cyclin A/Cdk-dependent relief of autorepression by the FoxM1 N-terminal domain. in Molecular and cellular biology 2008
Show all 2 references for ABIN2781166
Human Polyclonal FOXM1 Primary Antibody for WB - ABIN610565
Reeves, Helman, Allison, Israel: Molecular cloning and primary structure of human glial fibrillary acidic protein. in Proceedings of the National Academy of Sciences of the United States of America 1989
Human Polyclonal FOXM1 Primary Antibody for IF (p), IHC (p) - ABIN749138
Liu, Zhang, Mao, Zhang, Zhang: Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia. in Biochemical and biophysical research communications 2014
Our results indicate that FOXM1 overexpression may be a prognostic factor of RMS and that FOXM1 may be a promising therapeutic target for the inhibition of rhabdomyosarcoma progression
FoxM1 overexpression promotes hepatocellular carcinoma cell proliferation by cell cycle regulation
Data suggest that targeting microRNA miR (show MLXIP Antibodies)-149/forkhead box transcription factor (show FOXP2 Antibodies) (FOXM1) signaling will be a potential strategy in the treatment of 5-fluorouracil (5-FU)-chemoresistant colorectal cancer (CRC (show CALR Antibodies)).
Overexpression of FOXM1 reversed cell viability, migration, invasion and vimentin (show VIM Antibodies) levels suppressed by miR (show MLXIP Antibodies)-509-5p mimics in H1299 cells.
MCT1 (show CMA1 Antibodies) expression associates with the SCC (show CYP11A1 Antibodies) type and metastatic behavior of AC, whereas MCT4 (show SLC16A4 Antibodies) expression concomitantly increases from in situ SCC (show CYP11A1 Antibodies) to invasive SCC (show CYP11A1 Antibodies) and is significantly associated with the AC type. Consistently, FOXM1 expression is statistically associated with MCT1 (show CMA1 Antibodies) positivity in SCC (show CYP11A1 Antibodies), whereas the expression of FOXO3a (show FOXO3 Antibodies), a FOXM1 functional antagonist, is linked to MCT1 (show CMA1 Antibodies) negativity
CAV-1 (show CAV1 Antibodies), FOXM1 and AT1-R (show AGTR1 Antibodies) may be potential markers of tumorigenesis in certain types of cancer in vitro.
Overexpression of forkhead box protein M1 is associated with colorectal cancer.
data suggest that the pathogenesis of human colorectal cancer may be mediated by FOXM1, and that FOXM1 inhibition may provide a promising therapeutic strategy for CRC (show CALR Antibodies)
ACSL4 (show ACSL4 Antibodies), CGGBP1 (show CGGBP1 Antibodies) and PGRMC2 (show PGRMC2 Antibodies) were significantly downregulated with FOXM1 reduction in breast cancer cells, attenuating cell migration.
Data indicate that microRNA miR (show MLXIP Antibodies)-671-5p functions as a tumor suppressor in breast cancer by directly targeting forkhead box M1 (FOXM1).
EGF (show EGF Antibodies) promotes FoxM1 expression through the ERK (show EPHB2 Antibodies) signal pathway
FoxM1 induction in the pulmonary vasculature was inhibited by a p110gamma (show PIK3CG Antibodies)-selective inhibitor and in Pik3cg (show PIK3CG Antibodies)(-/-) mice after LPS (show TLR4 Antibodies) challenge. Defective vascular repair in Pik3cg (show PIK3CG Antibodies)-/- mice results from impaired FoxM1 expression
we suggest that proper regional decidualization and polyploidy development requires FoxM1 signaling downstream of Hoxa10 (show HOXA10 Antibodies) and cyclin D3 (show CCND3 Antibodies).
FOXM1 and CENPF (show CENPF Antibodies) are master regulators of prostate cancer malignancy, and can serve as drug response markers for antineoplastic drugs efficiency.
Both gain-of-function and loss-of-function TP53 (show TP53 Antibodies) mutations contribute to overexpression of FoxM1 in high-grade serous ovarian cancer.
MicroRNA-802 suppresses breast cancer proliferation through down-regulation of FoxM1.
FoxM1 expression correlates with proliferation, invasion and migration in mouse hepatocellular carcinoma cell lines.
activated FoxM1 increases beta-cell replication while simultaneously enhancing insulin (show INS Antibodies) secretion and improving glucose homeostasis, making FoxM1 an attractive therapeutic target for diabetes.
Data indicate transcription factor Foxm1 as a critical regulator of the quiescence and self-renewal of hematopoietic stem cells (HSCs).
SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene (show RAB1A Antibodies).
the sequence and expression pattern of FoxM1 (fork head box M1) transcription factor in Xenopus laevis embryos are described
Results suggest that FoxM1 functions to link cell division and neuronal differentiation in early Xenopus embryos.
The protein encoded by this gene is a transcriptional activator involved in cell proliferation. The encoded protein is phosphorylated in M phase and regulates the expression of several cell cycle genes, such as cyclin B1 and cyclin D1. Several transcript variants encoding different isoforms have been found for this gene.
forkhead box protein M1
, forkhead box M1
, forkhead box protein M1-like
, Forkhead, drosophila, homolog-like 16
, HNF-3/fork-head homolog 11
, M-phase phosphoprotein 2
, MPM-2 reactive phosphoprotein 2
, forkhead-related protein FKHL16
, hepatocyte nuclear factor 3 forkhead homolog 11
, transcription factor Trident
, winged-helix factor from INS-1 cells
, forkhead homolog 16
, winged-helix transcription factor Trident
, INS-1 winged helix